Cross-talk between PPARs and the partners of RXR: A molecular perspective

PPAR Research

Volumn , Issue , 2009, Pages

  Wells, Richard A ^a,b,c   Chan, Lap Shu Alan ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Sunnybrook Health Sciences Centre   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; HETERODIMER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RETINOID X RECEPTOR;

DIMERIZATION; DNA BINDING; DNA RESPONSIVE ELEMENT; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW;

EID: 75449096571     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2009/925309     Document Type: Review

References (82)

1. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 1990 347 6294 645 650
2. Okuno M., Arimoto E., Ikenobu Y., Nishihara T., Imagawa M., Dual DNA-binding specificity of peroxisome-proliferator-activated receptor γ controlled by heterodimer formation with retinoid X receptor γ, Biochemical Journal 2001 353 2 193 198
3. Tsai S. Y., Tsai M.-J., Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age Endocrine Reviews 1997 18 2 229 240
4. Mangelsdorf D. J., Evans R. M., The RXR heterodimers and orphan receptors Cell 1995 83 6 841 850
5. Giguere V., Orphan nuclear receptors: from gene to function Endocrine Reviews 1999 20 5 689 725
6. Bogan A. A., Dallas-Yang Q., Ruse M. D. Jr., Analysis of protein dimerization and ligand binding of orphan receptor HNF4α, Journal of Molecular Biology 2000 302 4 831 851
7. Lee C.-H., Chinpaisal C., Wei L.-N., A novel nuclear receptor heterodimerization pathway mediated by orphan receptors TR2 and TR4 Journal of Biological Chemistry 1998 273 39 25209 25215
8. Zetterstrom R. H., Solomin L., Mitsiadis T., Olson L., Perlmann T., Retinoid X receptor heterodimerization and developmental expression distinguish the orphan nuclear receptors NGFI-B, Nurr1, and Nor1 Molecular Endocrinology 1996 10 12 1656 1666
9. Hallenbeck P. L., Marks M. S., Lippoldt R. E., Ozato K., Nikodem V. M., Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXR) enhances DNA binding and TH-dependent transcriptional activation Proceedings of the National Academy of Sciences of the United States of America 1992 89 12 5572 5576
10. Seol W., Choi H.-S., Moore D. D., Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors Molecular Endocrinology 1995 9 1 72 85
11. Nishimura M., Naito S., Yokoi T., Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies Drug Metabolism and Pharmacokinetics 2004 19 2 135 149
12. Dolle P., Developmental expression of retinoic acid receptors (RARs) Nuclear Receptor Signaling 2009 7, article e006
13. Michalik L., Desvergne B., Dreyer C., Gavillet M., Laurini R. N., Wahli W., PPAR expression and function during vertebrate development International Journal of Developmental Biology 2002 46 1 105 114
14. Forrest D., Sjoberg M., Vennstrom B., Contrasting developmental and tissue-specific expression of and thyroid hormone receptor genes EMBO Journal 1990 9 5 1519 1528
15. Panda D. K., Kawas S. A., Seldin M. F., Hendy G. N., Goltzman D., 25-Hydroxyvitamin D 1-hydroxylase: structure of the mouse gene, chromosomal assignment, and developmental expression Journal of Bone and Mineral Research 2001 16 1 46 56
16. Jonk L. J., de Jonge M. E., Pals C. E., Cloning and expression during development of three murine members of the COUP family of nuclear orphan receptors Mechanisms of Development 1994 47 1 81 97
17. McKenna N. J., Cooney A. J., Demayo F. J., Minireview: evolution of NURSA, the nuclear receptor signaling atlas Molecular Endocrinology 2009 23 6 740 746
18. Umesono K., Murakami K. K., Thompson C. C., Evans R. M., Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors Cell 1991 65 7 1255 1266
19. Rastinejad F., Retinoid X receptor and its partners in the nuclear receptor family Current Opinion in Structural Biology 2001 11 1 33 38
20. Forman B. M., Evans R. M., Nuclear hormone receptors activate direct, inverted, and everted repeats Annals of the New York Academy of Sciences 1995 761 29 37
21. Rastinejad F., Perlmann T., Evans R. M., Sigler P. B., Structural determinants of nuclear receptor assembly on DNA direct repeats Nature 1995 375 6528 203 211
22. Zhao Q., Chasse S. A., Devarakonda S., Sierk M. L., Ahvazi B., Rastinejad F., Structural basis of RXR-DNA interactions Journal of Molecular Biology 2000 296 2 509 520
23. Rastinejad F., Wagner T., Zhao Q., Khorasanizadeh S., Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1 EMBO Journal 2000 19 5 1045 1054
24. Tugwood J. D., Issemann I., Anderson R. G., Bundell K. R., McPheat W. L., Green S., The mouse peroxisome proliferator activated receptor recognizes a response element in the 5 ′ flanking sequence of the rat acyl CoA oxidase gene EMBO Journal 1992 11 2 433 439
25. Chandra V., Huang P., Hamuro Y., Structure of the intact PPAR-RXR-nuclear receptor complex on DNA Nature 2008 456 7220 350 356
26. Mader S., Leroy P., Chen J.-Y., Chambon P., Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors Journal of Biological Chemistry 1993 268 1 591 600
27. Forman B. M., Casanova J., Raaka B. M., Ghysdael J., Samuels H. H., Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers Molecular Endocrinology 1992 6 3 429 442
28. Naar A. M., Boutin J.-M., Lipkin S. M., The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors Cell 1991 65 7 1267 1279
29. Kurokawa R., Soderstrom M., Horlein A., Polarity-specific activities of retinoic acid receptors determined by a co-repressor Nature 1995 377 6548 451 454
30. Kurokawa R., DiRenzo J., Boehm M., Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding Nature 1994 371 6497 528 531
31. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M., Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 1992 358 6389 771 774
32. Mangelsdorf D. J., Umesono K., Kliewer S. A., Borgmeyer U., Ong E. S., Evans R. M., A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR Cell 1991 66 3 555 561
33. Nakshatri H., Bhat-Nakshatri P., Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements Nucleic Acids Research 1998 26 10 2491 2499
34. IJpenberg A., Jeannin E., Wahli W., Desvergne B., Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element Journal of Biological Chemistry 1997 272 32 20108 20117
35. Vivat-Hannah V., Bourguet W., Gottardis M., Gronemeyer H., Separation of retinoid X receptor homo-and heterodimerization functions Molecular and Cellular Biology 2003 23 21 7678 7688
36. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D., Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-Nature 1995 375 6530 377 382
37. Bourguet W., Germain P., Gronemeyer H., Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications Trends in Pharmacological Sciences 2000 21 10 381 388
38. Nolte R. T., Wisely G. B., Westin S., Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-Nature 1998 395 6698 137 143
39. Bourguet W., Vivat V., Wurtz J.-M., Chambon P., Gronemeyer H., Moras D., Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains Molecular Cell 2000 5 2 289 298
40. Pogenberg V., Guichoul J.-F., Vivat-Hannah V., Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies Journal of Biological Chemistry 2005 280 2 1625 1633
41. Suino K., Peng L., Reynolds R., The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization Molecular Cell 2004 16 6 893 905
42. Xu R. X., Lambert M. H., Wisely B. B., A structural basis for constitutive activity in the human CAR/RXR heterodimer Molecular Cell 2004 16 6 919 928
43. Jaye M. C., Krawiec J. A., Campobasso N., Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure Journal of Medicinal Chemistry 2005 48 17 5419 5422
44. Svensson S., stberg T., Jacobsson M., Crystal structure of the heterodimeric complex of LXR and RXR ligand-binding domains in a fully agonistic conformation EMBO Journal 2003 22 18 4625 4633
45. Gampe R. T. Jr., Montana V. G., Lambert M. H., Asymmetry in the PPAR /RXR crystal structure reveals the molecular basis of heterodimerization among nuclear receptors Molecular Cell 2000 5 545 555
46. Xu H. E., Lambert M. H., Montana V. G., Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors Proceedings of the National Academy of Sciences of the United States of America 2001 98 24 13919 13924
47. Haffner C. D., Lenhard J. M., Miller A. B., Structure-based design of potent retinoid X receptor agonists Journal of Medicinal Chemistry 2004 47 8 2010 2029
48. Chen Z.-P., Iyer J., Bourguet W., Ligand-and DNA-induced dissociation of RXR tetramers Journal of Molecular Biology 1998 275 1 55 65
49. Dong D., Noy N., Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptors self-association properties Biochemistry 1998 37 30 10691 10700
50. Ide T., Shimano H., Yoshikawa T., Cross-talk between peroxisome proliferator-activated receptor (PPAR) and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling Molecular Endocrinology 2003 17 7 1255 1267 (Pubitemid 36819949)
51. Yoshikawa T., Ide T., Shimano H., Cross-talk between peroxisome proliferator-activated receptor (PPAR) and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. I. PPARS suppress sterol regulatory element binding protein-1c promoter through inhibition of LXR signaling Molecular Endocrinology 2003 17 7 1240 1254 (Pubitemid 36819948)
52. Miyata K. S., Zhang B., Marcus S. L., Capone J. P., Rachubinski R. A., Chicken ovalbumin upstream promoter transcription factor (COUP-TF) binds to a peroxisome proliferator-responsive element and antagonizes peroxisome proliferator-mediated signaling Journal of Biological Chemistry 1993 268 26 19169 19172
53. Hashimoto K., Cohen R. N., Yamada M., Cross-talk between thyroid hormone receptor and liver X receptor regulatory pathways is revealed in a thyroid hormone resistance mouse model Journal of Biological Chemistry 2006 281 1 295 302
54. Thompson P. D., Hsieh J.-C., Whitfield G. K., Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor Journal of Cellular Biochemistry 1999 75 3 462 480
55. Waxman D. J., P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR Archives of Biochemistry and Biophysics 1999 369 1 11 23
56. Zhang X.-K., Salbert G., Lee M.-O., Pfahl M., Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor Molecular and Cellular Biology 1994 14 6 4311 4323
57. Perlmann T., Umesono K., Rangarajan P. N., Forman B. M., Evans R. M., Two distinct dimerization interfaces differentially modulate target gene specificity of nuclear hormone receptors Molecular Endocrinology 1996 10 8 958 966
58. Lee S.-K., Lee B., Lee J. W., Mutations in retinoid X receptor that impair heterodimerization with specific nuclear hormone receptor Journal of Biological Chemistry 2000 275 43 33522 33526
59. Nakajima S., Hsieh J.-C., MacDonald P. N., The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D-responsive element Molecular Endocrinology 1994 8 2 159 172
60. Sucov H. M., Dyson E., Gumeringer C. L., Price J., Chien K. R., Evans R. M., RXR mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis Genes and Development 1994 8 9 1007 1018
61. Chen J., Kubalak S. W., Chien K. R., Ventricular muscle-restricted targeting of the RXR gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis Development 1998 125 10 1943 1949
62. Wu Y., Zhang X., Bardag-Gorce F., Retinoid X receptor regulates glutathione homeostasis and xenobiotic detoxification processes in mouse liver Molecular Pharmacology 2004 65 3 550 557
63. Imai T., Jiang M., Kastner P., Chambon P., Metzger D., Selective ablation of retinoid X receptor in hepatocytes impairs their lifespan and regenerative capacity Proceedings of the National Academy of Sciences of the United States of America 2001 98 8 4581 4586
64. Li M., Indra A. K., Warot X., Skin abnormalities generated by temporally controlled RXR mutations in mouse epidermis Nature 2000 407 6804 633 636
65. Chapellier B., Mark M., Messaddeq N., Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled EMBO Journal 2002 21 13 3402 3413
66. Huang J., Powell W. C., Khodavirdi A. C., Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor allele in the prostate epithelium Cancer Research 2002 62 16 4812 4819
67. Barak Y., Nelson M. C., Ong E. S., PPAR is required for placental, cardiac, and adipose tissue development Molecular Cell 1999 4 4 585 595
68. Rangwala S. M., Lazar M. A., Peroxisome proliferator-activated receptor in diabetes and metabolism Trends in Pharmacological Sciences 2004 25 6 331 336
69. Kubota N., Terauchi Y., Miki H., PPAR mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance Molecular Cell 1999 4 4 597 609
70. Chambon P., The retinoid signaling pathway: molecular and genetic analyses Seminars in Cell Biology 1994 5 2 115 125
71. Mark M., Ghyselinck N. B., Wendling O., A genetic dissection of the retinoid signalling pathway in the mouse Proceedings of the Nutrition Society 1999 58 2 609 613
72. Hondares E., Mora O., Yubero P., Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1 gene transcription: an autoregulatory loop controls PGC-1 expression in adipocytes via peroxisome proliferator-activated receptor-coactivation Endocrinology 2006 147 6 2829 2838
73. Teruel T., Clapham J. C., Smith S. A., PPAR activation by Wy 14643 induces transactivation of the Rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPAR-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes Biochemical and Biophysical Research Communications 1999 264 2 311 315
74. Berger J., Leibowitz M. D., Doebber T. W., Novel peroxisome proliferator-activated receptor (PPAR) and PPAR ligands produce distinct biological effects Journal of Biological Chemistry 1999 274 10 6718 6725
75. Cobb J. E., Blanchard S. G., Boswell E. G., N-(2-benzoylphenyl)-L- tyrosine PPAR agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent Journal of Medicinal Chemistry 1998 41 25 5055 5069
76. Wright H. M., Clish C. B., Mikami T., A synthetic antagonist for the peroxisome proliferator-activated receptor inhibits adipocyte differentiation Journal of Biological Chemistry 2000 275 3 1873 1877
77. Mukherjee R., Hoener P. A., Jow L., A selective peroxisome proliferator-activated receptor-(PPAR) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes Molecular Endocrinology 2000 14 9 1425 1433
78. He T.-C., Chan T. A., Vogelstein B., Kinzler K. W., PPAR is an APC-regulated target of nonsteroidal anti-inflammatory drugs Cell 1999 99 3 335 345
79. Chaffer C. L., Thomas D. M., Thompson E. W., Williams E. D., PPAR-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma BMC Cancer 2006 6, article 53
80. Yang C.-C., Ku C.-Y., Wei S., Peroxisome proliferator-activated receptor-independent repression of prostate-specific antigen expression by thiazolidinediones in prostate cancer cells Molecular Pharmacology 2006 69 5 1564 1570
81. Aggarwal S., Kim S.-W., Cheon K., Tabassam F. H., Yoon J.-H., Koo J. S., Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells Molecular Biology of the Cell 2006 17 2 566 575
82. Chan L. S., Wells R. A., Manipulation of reciprocal salt bridges at the heterodimerization interface alters the dimerization properties of mouse RXR and PPAR 1 Biochemical and Biophysical Research Communications 2007 358 4 1080 1085